Emilia vexler
01/06/2021 12:19
Clarín.com
Society
Updated 01/06/2021 12:19
The National Vaccination Campaign against Covid 19, which began last week throughout the country with a focus on health personnel, already has its Second Safety Report on the
Sputnik
V
vaccine
: 1,088 cases of mild and moderate adverse effects were reported after the first 39,599 doses applied.
In the first report, five days ago and with 32 thousand doses inoculated, the vaccinated people who had symptoms attributable to the vaccine were 317. The percentage of vaccinated who showed adverse effects, then, today is 2.7%.
Beyond this increase in the number of adverse effects reported between the first report and the current one, experts explain to
Clarín
that the important fact is that 99% of these symptoms were
mild and moderate
.
And they were repeated: fever, headache and myalgia.
From the Ministry of Health of the Nation reported this Wednesday that until 6:00 p.m. on January 3, 1,088 ESAVI were notified to the Integrated Health Information System of Argentina (SIISA), that is,
adverse effects after vaccination
after the application of 7,586 new doses reported in the Federal Register of Nominal Vaccination (NoMiVac).
39.7% of the adverse effects reported correspond to people with fever, headache and / or myalgia that started 6 to 8 hours after vaccination.
99.3% of the reported events were mild and moderate.
Among the expected reactions after receiving the Sputnik V vaccine, pain at the injection site, hyperemia, and swelling may occur.
Also systemic reactions:
short-lived flu-like syndrome
with onset within 24 to 48 hours (characterized by chills, fever, arthralgia, myalgia, asthenia, malaise, headache) or less frequent gastrointestinal symptoms (nausea, dyspepsia, decreased appetite) .
These reactions last an average of 24 hours.
They also reported that 22 of the 24 jurisdictions have notified ESAVI to SIISA.
"97.7% of the effects are mild. 92.5% referred to muscle pain at the injection site and headache," remarked the Deputy Minister of Health, Carla Vizzotti, at the press conference on Wednesday.
"These events are mild, they start within 6 and 8 hours of vaccination and last 24 hours," he added.
When analyzing the new report on Sputnik V, the infectologist Eduardo López marks a 2.5% increase in adverse effects, but emphasizes that
no case was serious or required hospitalization
.
"The vast majority of the cases were mild and moderate adverse effects. Until today,
that is a very good figure
. What to watch, always, are the serious adverse effects, which are what really matter, because they can force hospitalization eventually to a patient and have him or her under observation for a long time. The level of 'concern' about these effects is low, especially since they are reported at the injection site: pain or edema ", explains López.
Another point that, for the infectologist, generates "confidence" in this vaccine is that, in general, "serious adverse effects
begin within a few hours of receiving the injection
", so there would be no greater risk for the people who received the
injection.
first dose and showed mild symptoms attributable to Sputnik V.
The studies on Sputnik V published in the scientific journal The Lancet do not count the total number of patients who reported adverse effects, but what they were: 58% corresponded to pain at the injection site and 42% to headache. which marks as
"expected"
the symptoms reported in the first and second safety reports on vaccines in Argentina.
ACE
Look also
Sputnik V: in what state is the national vaccination campaign against the coronavirus
Vladimir Putin and Angela Merkel analyze the "joint production of vaccines" against the coronavirus